Looming obesity drug rivalry not a concern for Novo CEO

cafead

Administrator
Staff member
  • cafead   Nov 16, 2022 at 10:52: AM
via The demand for obesity drugs like Novo Nordisk’s Wegovy is so great that the company isn’t too worried about the entrance of rival drugs, Novo Nordisk CEO Lars Jorgensen said on Tuesday.

article source